Andrea Anampa-Guzmán

11PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Collaborative and social computing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 18, 2024
Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study.

Natalie S Grover, Kaitlin Annunzio, Marcus Watkins

|Oct 04, 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study.

Kaitlin Annunzio, Natalie S Grover, Rina Li Welkie

|Jun 14, 2023
Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study.

Narendranath Epperla, Qiuhong Zhao, Reem Karmali

|Nov 14, 2022
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL.

Pallawi Torka, Adrienne Groman, Jerry Wong

|Mar 28, 2022
The Rise of the Expert Patient in Cancer: From Backseat Passenger to Co-navigator.

Andrea Anampa-Guzmán, Janet Freeman-Daily, Michael Fisch

|Nov 29, 2021
ASCO-Sponsored Oncology Student Interest Groups in the World.

Andrea Anampa-Guzmán, Silvana Loli-Guevara, Cristian Antonio Gutierrez-Narvaez

Pageof 2

Frequent Collaborators

3 joint publications

Adam J Olszewski

3 joint publications

Reem Karmali

3 joint publications

Natalie S Grover

3 joint publications

Narendranath Epperla